VP shunt infections
Revision as of 19:46, 25 May 2015 by Rossdonaldson1 (talk | contribs) (Created page with "==Background== ===Causative agents=== *S. epi *S. aureus *Coliforms ==Clinical Features== ==Differential Diagnosis== ==Diagnosis== ==Management== ===Pediatric=== {{Pediat...")
Background
Causative agents
- S. epi
- S. aureus
- Coliforms
Clinical Features
Differential Diagnosis
Diagnosis
Management
Pediatric
- Empiric therapy: Vancomycin AND Cefotaxime 200 mg/kg/day IV div Q6 OR ceftriaxone 100 mg/kg/day IV div Q12-24
- Always involved neurosurgery in management
- Tailor antimicrobial therapy to culture results